Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Incyte Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
INCY
Nasdaq
2836
www.incyte.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Incyte Corporation
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Feb 7th, 2025 9:30 pm
Will Blueprint Medicines (BPMC) Report Negative Earnings Next Week? What You Should Know
- Feb 6th, 2025 3:01 pm
Curious about Incyte (INCY) Q4 Performance? Explore Wall Street Estimates for Key Metrics
- Feb 5th, 2025 2:15 pm
Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know
- Feb 4th, 2025 4:47 pm
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
- Feb 3rd, 2025 3:00 pm
Exploring High Growth Tech Stocks In January 2025
- Jan 30th, 2025 2:03 pm
Incyte to Report Fourth Quarter and Year-End 2024 Financial Results
- Jan 21st, 2025 1:00 pm
Incyte Gains 15.3% in a Year: Is There Room for Further Growth?
- Jan 20th, 2025 7:35 pm
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
- Jan 15th, 2025 10:34 pm
JP Morgan 2025: Incyte expects period of ‘defining catalysts’
- Jan 15th, 2025 1:54 pm
Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines
- Jan 15th, 2025 8:48 am
5 Biotech Stocks Worth Adding to Your Portfolio in 2025
- Jan 14th, 2025 3:02 pm
Has Incyte (INCY) Outpaced Other Medical Stocks This Year?
- Jan 13th, 2025 2:40 pm
Incyte Highlights Commercial Growth, Clinical Progress and 2025 Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 13th, 2025 1:30 pm
INCY vs. VRTX: Which Stock Is the Better Value Option?
- Jan 10th, 2025 4:40 pm
Exploring Three High Growth Tech Stocks in the United States
- Dec 27th, 2024 2:06 pm
EXEL vs. INCY: Which Stock Should Value Investors Buy Now?
- Dec 25th, 2024 4:40 pm
Incyte price target raised to $70 from $68 at Wells Fargo
- Dec 20th, 2024 12:20 pm
MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease
- Dec 19th, 2024 6:16 pm
Incyte to Present at Upcoming Investor Conference
- Dec 17th, 2024 1:00 pm
Scroll